FDA PET radiopharmaceuticals policy
This article was originally published in The Gray Sheet
Executive Summary
The agency is discussing its proposed policy on the regulation of positron emission tomography radiopharmaceuticals at a public hearing March 5. The draft policy, entitled "Regulatory Approach to PET Radiopharmaceuticals," is expected to be available in several weeks....